These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Suppression of STAT3 Signaling by Δ9-Tetrahydrocannabinol (THC) Induces Trophoblast Dysfunction. Chang X; Bian Y; He Q; Yao J; Zhu J; Wu J; Wang K; Duan T Cell Physiol Biochem; 2017; 42(2):537-550. PubMed ID: 28578322 [TBL] [Abstract][Full Text] [Related]
6. Cannabis abuse and addiction: a contemporary literature review. Iyalomhe GB Niger J Med; 2009; 18(2):128-33. PubMed ID: 19630315 [TBL] [Abstract][Full Text] [Related]
7. The neuropsychopharmacology of cannabis: A review of human imaging studies. Bloomfield MAP; Hindocha C; Green SF; Wall MB; Lees R; Petrilli K; Costello H; Ogunbiyi MO; Bossong MG; Freeman TP Pharmacol Ther; 2019 Mar; 195():132-161. PubMed ID: 30347211 [TBL] [Abstract][Full Text] [Related]
8. Addiction and the pharmacology of cannabis: implications for medicine and the law. Lader M Med Sci Law; 2009 Jan; 49(1):1-17. PubMed ID: 19306615 [TBL] [Abstract][Full Text] [Related]
9. fMRI study of neural sensitization to hedonic stimuli in long-term, daily cannabis users. Filbey FM; Dunlop J; Ketcherside A; Baine J; Rhinehardt T; Kuhn B; DeWitt S; Alvi T Hum Brain Mapp; 2016 Oct; 37(10):3431-43. PubMed ID: 27168331 [TBL] [Abstract][Full Text] [Related]
10. Effect of delta9-tetrahydrocannabinol on phosphorylated CREB in rat cerebellum: an immunohistochemical study. Casu MA; Pisu C; Sanna A; Tambaro S; Spada GP; Mongeau R; Pani L Brain Res; 2005 Jun; 1048(1-2):41-7. PubMed ID: 15913574 [TBL] [Abstract][Full Text] [Related]
11. Preclinical Studies of Cannabinoid Reward, Treatments for Cannabis Use Disorder, and Addiction-Related Effects of Cannabinoid Exposure. Panlilio LV; Justinova Z Neuropsychopharmacology; 2018 Jan; 43(1):116-141. PubMed ID: 28845848 [TBL] [Abstract][Full Text] [Related]
12. The Problem with the Current High Potency THC Marijuana from the Perspective of an Addiction Psychiatrist. Stuyt E Mo Med; 2018; 115(6):482-486. PubMed ID: 30643324 [No Abstract] [Full Text] [Related]
13. Psychoactive Drugs Like Cannabis -Induce Hypodopaminergic Anhedonia and Neuropsychological Dysfunction in Humans: Putative Induction of Dopamine Homeostasis via Coupling of Genetic Addiction Risk Severity (GARS) testing and Precision Pro-dopamine Regulation (KB220). Blum K; Morgan J; Cadet JL; Baron D; Carney PR; Khalsa J; Badgaiyan RD; Gold MS Neurology (ECronicon); 2021 Apr; 13(4):86-92. PubMed ID: 34085060 [TBL] [Abstract][Full Text] [Related]
14. Behavioral and molecular changes elicited by acute administration of SR141716 to Delta9-tetrahydrocannabinol-tolerant rats: an experimental model of cannabinoid abstinence. González S; Fernández-Ruiz J; Di Marzo V; Hernández M; Arévalo C; Nicanor C; Cascio MG; Ambrosio E; Ramos JA Drug Alcohol Depend; 2004 May; 74(2):159-70. PubMed ID: 15099659 [TBL] [Abstract][Full Text] [Related]
15. The Role of Cannabinoids in Neuroanatomic Alterations in Cannabis Users. Lorenzetti V; Solowij N; Yücel M Biol Psychiatry; 2016 Apr; 79(7):e17-31. PubMed ID: 26858212 [TBL] [Abstract][Full Text] [Related]
16. Marijuana dependence: not just smoke and mirrors. Ramesh D; Schlosburg JE; Wiebelhaus JM; Lichtman AH ILAR J; 2011; 52(3):295-308. PubMed ID: 23382144 [TBL] [Abstract][Full Text] [Related]